Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial

✍ Scribed by Jeffrey S. Berger; Matthew T. Roe; C. Michael Gibson; Rakhi Kilaru; Cynthia L. Green; Laura Melton; James D. Blankenship; D. Christopher Metzger; Christopher B. Granger; Daniel D. Gretler; Cindy L. Grines; Kurt Huber; Uwe Zeymer; Pawel Buszman; Robert A. Harrington; Paul W. Armstrong

• Book ID: 116191934
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 239 KB
• Volume: 158
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2009.10.010